| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Robert Blum, Klaus-Peter Lesc. Parkinson's disease, anxious depression and serotonin--zooming in on hippocampal neurogenesis. Journal of neurochemistry. vol 135. issue 3. 2016-02-11. PMID:26382574. |
parkinson's disease, anxious depression and serotonin--zooming in on hippocampal neurogenesis. |
2016-02-11 |
2023-08-13 |
Not clear |
| John D McCorvy, Bryan L Rot. Structure and function of serotonin G protein-coupled receptors. Pharmacology & therapeutics. vol 150. 2016-02-08. PMID:25601315. |
serotonin receptors are prevalent throughout the nervous system and the periphery, and remain one of the most lucrative and promising drug discovery targets for disorders ranging from migraine headaches to neuropsychiatric disorders such as schizophrenia and depression. |
2016-02-08 |
2023-08-13 |
Not clear |
| George Anderson, Moses Rodrigue. Multiple sclerosis: the role of melatonin and N-acetylserotonin. Multiple sclerosis and related disorders. vol 4. issue 2. 2016-02-08. PMID:25787187. |
many of the changes occurring in ms, including increased mitochondrial dysfunction, pain reporting and depression may be partly mediated by increased indoleamine 2,3-dioxygenase, which drives tryptophan to the production of neuroregulatory tryptophan catabolites and away from serotonin, n-acetylserotonin and melatonin production. |
2016-02-08 |
2023-08-13 |
Not clear |
| Yina Ma, Bingfeng Li, Chenbo Wang, Wenxia Zhang, Yi Rao, Shihui Ha. Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network. The British journal of psychiatry : the journal of mental science. vol 206. issue 5. 2016-02-04. PMID:25745133. |
selective serotonin reuptake inhibitors (ssris), such as citalopram, which selectively block serotonin transporter (5-htt) activity, are widely used in the treatment of depression and anxiety disorders. |
2016-02-04 |
2023-08-13 |
Not clear |
| David Kitchin. Depression in dementia. Australian prescriber. vol 38. issue 6. 2016-02-04. PMID:26843714. |
selective serotonin reuptake inhibitors are the first-line pharmacotherapy for depression in dementia, although they are less likely to be effective in older people. |
2016-02-04 |
2023-08-13 |
Not clear |
| Shu-Juan Wu, Ren-Ye Wang, Ji-Xiong Xue, Jian-Chun Pa. [Effect of piperine on 5-HT and synaptophysin expression of rats with irritable bowel syndrome]. Yao xue xue bao = Acta pharmaceutica Sinica. vol 48. issue 12. 2016-02-02. PMID:24689235. |
the presence of depression and visceral sensitivity had been changed in ibs rats, with abnormal expression of 5-ht and synaptophysin in the brain-gut system. |
2016-02-02 |
2023-08-12 |
rat |
| Vladimir V Matchkov, Violetta V Kravtsova, Ove Wiborg, Christian Aalkjaer, Elena V Bouzinov. Chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression. American journal of physiology. Regulatory, integrative and comparative physiology. vol 309. issue 8. 2016-02-01. PMID:26269522. |
chronic selective serotonin reuptake inhibition modulates endothelial dysfunction and oxidative state in rat chronic mild stress model of depression. |
2016-02-01 |
2023-08-13 |
rat |
| Zhengchao Xia, Hongyan Wei, Jingjing Duan, Ting Zhou, Zhen Yang, Feng X. Chronic unpredicted mild stress-induced depression alter saxagliptin pharmacokinetics and CYP450 activity in GK rats. PeerJ. vol 4. 2016-01-28. PMID:26819853. |
plasma serotonin and dopamine levels and behavior of open-field test were used to confirm the establishment of the depression model. |
2016-01-28 |
2023-08-13 |
rat |
| Tomislav Radocaj, Sanda Mustapic, Ivana Prkic, Astrid G Stucke, Francis A Hopp, Eckehard A E Stuth, Edward J Zuperk. Activation of 5-HT1A receptors in the preBötzinger region has little impact on the respiratory pattern. Respiratory physiology & neurobiology. vol 212-214. 2016-01-27. PMID:25850079. |
the prebötzinger (prebötc) complex has been suggested as the primary site where systemically administered selective serotonin agonists have been shown to reduce or prevent opioid-induced depression of breathing. |
2016-01-27 |
2023-08-13 |
dog |
| Joshua Kaufman, Gregory M Sullivan, Jie Yang, R Todd Ogden, Jeffrey M Miller, Maria A Oquendo, J John Mann, Ramin V Parsey, Christine DeLorenz. Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 40. issue 7. 2016-01-25. PMID:25578798. |
quantification of the serotonin 1a receptor using pet: identification of a potential biomarker of major depression in males. |
2016-01-25 |
2023-08-13 |
human |
| Barbara Horváth, Ineke C Janse, Gary R Sibbal. Pain management in patients with hidradenitis suppurativa. Journal of the American Academy of Dermatology. vol 73. issue 5 Suppl 1. 2016-01-22. PMID:26470616. |
in addition, anticonvulsants and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors possess neuropathic pain-relieving properties that offer not only control of hs-associated pain but beneficial effects on itch and depression. |
2016-01-22 |
2023-08-13 |
Not clear |
| P Homan, A Neumeister, A C Nugent, D S Charney, W C Drevets, G Hasle. Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression. Translational psychiatry. vol 5. 2016-01-20. PMID:25781231. |
serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression. |
2016-01-20 |
2023-08-13 |
human |
| P Homan, A Neumeister, A C Nugent, D S Charney, W C Drevets, G Hasle. Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression. Translational psychiatry. vol 5. 2016-01-20. PMID:25781231. |
in conclusion, this study showed that serotonin and catecholamines have common and differential roles in the pathophysiology of depression. |
2016-01-20 |
2023-08-13 |
human |
| H C Tsai, S-H Lin, P S Chen, H H Chang, I H Lee, T L Yeh, K C Chen, N T Chiu, W J Yao, M-H Liao, Y K Yan. Quantifying midbrain serotonin transporter in depression: a preliminary study of diagnosis and naturalistic treatment outcome. Pharmacopsychiatry. vol 48. issue 2. 2016-01-18. PMID:25626060. |
quantifying midbrain serotonin transporter in depression: a preliminary study of diagnosis and naturalistic treatment outcome. |
2016-01-18 |
2023-08-13 |
Not clear |
| James McKean, Hannah Watts, Robert Mokszyck. Breakthrough seizures after starting vilazodone for depression. Pharmacotherapy. vol 35. issue 3. 2016-01-15. PMID:25809181. |
vilazodone is a new selective serotonin reuptake inhibitor (ssri) and serotonin 5-ht1a partial agonist that is approved by the united states food and drug administration to treat major depression. |
2016-01-15 |
2023-08-13 |
Not clear |
| Hee-Ju Kang, Kyung-Yeol Bae, Sung-Wan Kim, Il-Seon Shin, Young Joon Hong, Youngkeun Ahn, Myung Ho Jeong, Sung-Woo Park, Young-Hoon Kim, Jin-Sang Yoon, Jae-Min Ki. Associations between Serotonergic Genes and Escitalopram Treatment Responses in Patients with Depressive Disorder and Acute Coronary Syndrome: The EsDEPACS Study. Psychiatry investigation. vol 13. issue 1. 2016-01-15. PMID:26766959. |
genes related to serotonin are associated with responses to treatment for depression. |
2016-01-15 |
2023-08-13 |
Not clear |
| Francesc Artiga. Developments in the field of antidepressants, where do we go now? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 25. issue 5. 2016-01-13. PMID:23706576. |
on the monoamine side, new preclinical and clinical research should clarify the different roles played by 5-ht receptors in depression as well as the brain areas and circuits responsible for therapeutic improvement. |
2016-01-13 |
2023-08-12 |
Not clear |
| Shunjie Bai, Chanjuan Zhou, Pengfei Cheng, Yuying Fu, Liang Fang, Wen Huang, Jia Yu, Weihua Shao, Xinfa Wang, Meiling Liu, Jingjing Zhou, Peng Xi. 1H NMR-based metabolic profiling reveals the effects of fluoxetine on lipid and amino acid metabolism in astrocytes. International journal of molecular sciences. vol 16. issue 4. 2016-01-12. PMID:25884334. |
fluoxetine, a selective serotonin reuptake inhibitor (ssri), is a prescribed and effective antidepressant and generally used for the treatment of depression. |
2016-01-12 |
2023-08-13 |
Not clear |
| Shehnaz Abdul Sheikh, Huma Ikram, Darakhshan Jabeen Halee. Behavioral deficits in rats following acute administration of glimepiride: Relationship with brain serotonin and dopamine. Pakistan journal of pharmaceutical sciences. vol 28. issue 4. 2016-01-11. PMID:26142509. |
since a decrease in 5-ht metabolism can induce depression-like effects, the present study therefore suggests that the occurrence of depression in diabetic patients is due to the use of glimipride. |
2016-01-11 |
2023-08-13 |
rat |
| Beverly H Brummett, Michael A Babyak, Redford B Williams, Kathleen Mullan Harris, Rong Jiang, William E Kraus, Abanish Singh, Paul T Costa, Anastasia Georgiades, Ilene C Siegle. A putatively functional polymorphism in the HTR2C gene is associated with depressive symptoms in white females reporting significant life stress. PloS one. vol 9. issue 12. 2016-01-08. PMID:25514629. |
activity of the x-linked serotonin 5-htr2c receptor has also been shown to be associated with depression and with clinical response to antidepressant medications. |
2016-01-08 |
2023-08-13 |
Not clear |